Skip to main content

Infrastructure & Innovation

Infrastructure & Innovation
Details infrastructure for effective pathways, including, but not limited to coordination among pathway elements, data systems informatics/data architecture, AI and machine learning models, and data integration.

CPC+CBEx Conference Highlights
12/15/2025
Gordon Kuntz
Gordon Kuntz provides a recap of the 9th annual Clinical Pathways Congress + Cancer Care Business Exchange (CPC+CBEx), highlighting important themes and notable sessions.
Gordon Kuntz provides a recap of the 9th annual Clinical Pathways Congress + Cancer Care Business Exchange (CPC+CBEx), highlighting important themes and notable sessions.
Gordon Kuntz provides a recap of...
12/15/2025
Journal of Clinical Pathways
Original Research
12/15/2025
Lisa Raff, PharmD; Rozanne Wilson, PhD; Richard Murphy, BA; Amal Jamaleddine, BA; Nicole Bariahtaris, BA; Meaghan Roach, MPH
A community-derived playbook from OneOncology outlines practical strategies for delivering teclistamab step-up dosing in outpatient settings, enabling safer, more convenient access for patients.
A community-derived playbook from OneOncology outlines practical strategies for delivering teclistamab step-up dosing in outpatient settings, enabling safer, more convenient access for patients.
A community-derived playbook...
12/15/2025
Journal of Clinical Pathways
Conference Coverage
09/09/2025
Grace Taylor, MS, MA
In this panel from CPC+CBEx, experts explore how artificial intelligence (AI) is emerging as a “thought partner” in health care, helping clinicians and practices manage rising complexity and improve outcomes while preserving the human touch...
In this panel from CPC+CBEx, experts explore how artificial intelligence (AI) is emerging as a “thought partner” in health care, helping clinicians and practices manage rising complexity and improve outcomes while preserving the human touch...
In this panel from CPC+CBEx,...
09/09/2025
Journal of Clinical Pathways
Conference Coverage
09/09/2025
Grace Taylor, MS, MA
From streamlining documentation to reshaping prior authorization, a panel of experts reveal how artificial intelligence (AI) is changing the realities of cancer care—and the challenges that come with it.
From streamlining documentation to reshaping prior authorization, a panel of experts reveal how artificial intelligence (AI) is changing the realities of cancer care—and the challenges that come with it.
From streamlining documentation...
09/09/2025
Journal of Clinical Pathways
Conference Coverage
09/08/2025
Grace Taylor, MS, MA
In his keynote address, Thomas Koulopoulos argues that the true future of health care lies not in technology alone but in reimagining human behaviors to create a seamless, patient-driven system empowered by artificial intelligence (AI).
In his keynote address, Thomas Koulopoulos argues that the true future of health care lies not in technology alone but in reimagining human behaviors to create a seamless, patient-driven system empowered by artificial intelligence (AI).
In his keynote address, Thomas...
09/08/2025
Journal of Clinical Pathways
Abstracts
08/25/2025
Eileen Campetti, PA-C, MS; Saranga Arora, MS, MBA; Helena Hay; Jennifer Siggia, RN, MSN; Stephen Speicher, MD, MS
In a pre-post study across 258 oncology clinics, integration of DeepScribe’s oncology-specific artificial intelligence (AI) scribe into the Flatiron Health OncoEMR electronic health record (EHR) system resulted in high adoption (98%),...
In a pre-post study across 258 oncology clinics, integration of DeepScribe’s oncology-specific artificial intelligence (AI) scribe into the Flatiron Health OncoEMR electronic health record (EHR) system resulted in high adoption (98%),...
In a pre-post study across 258...
08/25/2025
Journal of Clinical Pathways
Abstracts
08/25/2025
Aimee Ginsburg, PharmD, BCPS; Daniel Rubin, PharmD, BCOP; Victoria Handy, PharmD, BCOP; Steven Gilmore, PharmD, BCOP; Stephen Clark, PharmD, BCOP
Initially developed to support the Pathways Task Force (PTF) within the Value Pathways powered by the National Comprehensive Cancer Network (NCCN), embedded evidence tables summarizing clinical trial data—including patient-reported...
Initially developed to support the Pathways Task Force (PTF) within the Value Pathways powered by the National Comprehensive Cancer Network (NCCN), embedded evidence tables summarizing clinical trial data—including patient-reported...
Initially developed to support...
08/25/2025
Journal of Clinical Pathways
Abstracts
08/25/2025
Kristy L. Johnson; Jeffrey Minehart; Molly Lieber
In a pilot study at UChicago Medicine, Flatiron Clinical Pipe—a study-agnostic electronic health record (EHR)–to–electronic data capture (EDC) integration tool—automated the transfer of 4700 structured data points across two gastrointestinal...
In a pilot study at UChicago Medicine, Flatiron Clinical Pipe—a study-agnostic electronic health record (EHR)–to–electronic data capture (EDC) integration tool—automated the transfer of 4700 structured data points across two gastrointestinal...
In a pilot study at UChicago...
08/25/2025
Journal of Clinical Pathways
Abstracts
08/25/2025
Victoria Handy, PharmD, BCOP; Daniel Rubin, PharmD, BCOP; Steven Gilmore, PharmD, BCOP; Stephen Clark, PharmD, BCOP; Aimee Ginsburg, PharmD, BCPS
To improve workflow efficiency and clinical decision-making, the Clear Value Plus (CVP) clinical decision support (CDS) tool integrated Launch N’ Learn—an embedded feature providing point-of-care access to staging criteria and guideline-based...
To improve workflow efficiency and clinical decision-making, the Clear Value Plus (CVP) clinical decision support (CDS) tool integrated Launch N’ Learn—an embedded feature providing point-of-care access to staging criteria and guideline-based...
To improve workflow efficiency...
08/25/2025
Journal of Clinical Pathways
Abstracts
08/25/2025
Victoria Handy, PharmD, BCOP; Daniel Rubin, PharmD, BCOP; Steven Gilmore, PharmD, BCOP; Stephen Clark, PharmD, BCOP; Aimee Ginsburg, PharmD, BCPS
A retrospective analysis of 84 oncology drug approvals from January 2024 to June 2025 demonstrated that the US Oncology Network’s Pathways Task Force (PTF) conducted timely reviews—averaging 54 days post–US Food and Drug Administration (FDA)...
A retrospective analysis of 84 oncology drug approvals from January 2024 to June 2025 demonstrated that the US Oncology Network’s Pathways Task Force (PTF) conducted timely reviews—averaging 54 days post–US Food and Drug Administration (FDA)...
A retrospective analysis of 84...
08/25/2025
Journal of Clinical Pathways